Houston Elmiron Lawsuit Attorneys
Hundreds of people are suing Janssen Pharmaceuticals after taking Elmiron and experiencing vision problems that could lead to blindness, including maculopathy.
According to an Elmiron lawsuit, the manufacturer did not advise doctors and patients about the risks of the drug, including Elmiron eye damage. Elmiron has been called a critically defective medicine. The company stands accused of suppressing adverse event information from the public, medical community, and the Food & Drug Administration.
Injured individuals are filing these lawsuits to seek financial recompense for medical expenditures, pain and suffering, lost wages, diminished quality of life, and future care.
If you’ve suffered Elmiron eye damage or vision loss, you may be entitled to financial compensation. Contact our Houston pharmaceutical injuries attorneys at Reich & Binstock to go over your Elmiron lawsuit options.
What Is Elmiron?
The drug pentosan polysulfate sodium is marketed under the brand name Elmiron. Pentosan polysulfate helps prevent blood clots. The majority of the medications in this category are used to thin the blood, however, the prescription drug Elmiron is used to treat interstitial cystitis, a painful bladder syndrome.
Interstitial Cystitis (IC), a chronic bladder condition that causes chronic pain, discomfort, and frequent urination. IC affects approximately 12 million people in the United States. By preventing irritation and swelling of the bladder walls, Elmiron aids in the treatment of IC symptoms. The medicine is believed to create a synthetic mucus layer that protects the bladder from discomfort.
Janssen Pharmaceuticals Inc. developed and produces Elmiron. The manufacturer is a corporate subsidiary of Johnson & Johnson. The drug received FDA approval in 1996 and became the main treatment option for IC sufferers. The drug is also prescribed to treat bladder pain stemming from UTIs.
What is Interstitial Cystitis(IC)/Bladder Pain Syndrome?
Interstitial cystitis (IC) or bladder pain syndrome (BPS) is an ongoing bladder health problem. The bladder area experiences pain and pressure. Often, without infection or any other obvious causes, lower urinary tract symptoms occur for more than 6 weeks as well.
The bladder and kidneys are the organs in our bodies producing, storing, and passing urine. This is all part of the body’s urinary system. Our kidneys make urine and the bladder stores it. Muscles in the lower part of your abdomen hold the bladder in place.
Some patients’ symptoms come and go, while others experience constant pain. The symptoms also range for each patient, from mild to severe.
During sex, women with IC/BPS may have pain. Often accompanying IC/BPS, are irritable bowel syndrome, fibromyalgia, and other pain conditions.
Elmiron (pentosan polysulfate sodium) is a prescription medicine used to treat chronic bladder pain and inflammation and other diseases in millions of Americans. However, it was reported in 2018 that long-term use of the drug can result in Elmiron eye damage and blindness. This is due to a rare type of retinal injury.
One study confirmed this drug can cause maculopathy, a serious eye condition. As many as 1/4 of Elmira users can potentially go blind.
Elmiron patients frequently do not associate their vision problems with the medicine. Prior to the discovery of the association between Elmiron and permanent vision loss, doctors blamed worsening vision on age-related macular diseases.
Elmiron drug toxicity causes hazardous poisons to build up in the eyes, especially around the macula and retina. The following are some of the most common indicators of Elmiron drug toxicity:
- Hazy vision
- Low-light vision problems
- Pain in the eyes
- Blindness (complete or partial)
- Difficulty reading
The American Academy of Ophthalmology published a paper in 2018 describing six Emory Eye Center patients who developed pigmentary maculopathy of unknown cause after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis.
One of the authors updated these results in 2019. A total of 11 Emory Eye Center study participants were diagnosed with the same visual symptoms. These included loss of low light vision, generalized dimming of vision, difficulties reading, and general near-vision impairment.
While indications show the prescription drug Elmiron can cause life-altering eye disease, the drug hasn’t been shown to be effective in treating interstitial cystitis.
The United States Judicial Panel on Multidistrict Litigation issued an order on December 15, 2020, to construct a multidistrict litigation (MDL) for the federal claims. They predicted that there could be hundreds more lawsuits against Janssen Pharmaceuticals.
An MDL is a legal procedure that combines many federal cases into one. It is tried in a single court to make it easier to handle complicated cases. The Elmiron MDL order merged close to 130 existing lawsuits.
Anyone diagnosed with maculopathy or other eye disorders such as macular degeneration, pigmentary maculopathy, or blurred vision after taking the prescription drug Elmiron may be eligible for financial compensation from the drug manufacturer. As patients learn of the negative side effects, the number of Elmiron lawsuits will likely go up.
What Are the Criteria for Filing An Elmiron Lawsuit?
In order to file an Elmiron case, you must meet the following requirements:
- You took Elmiron for at least two years
- You experienced vision changes and negative side effects between starting the drug and up to one year after stopping
Medical studies tying the medication to macular diseases, such as interstitial cystitis and maculopathy, formed the basis for the criteria. There may be exceptions when you file your case, possibly making you eligible to claim for different types of eye injuries.
What Compensation Is Available In an Elmiron Lawsuit?
Our Houston personal injury lawyers seek the following compensation for Elmiron users who developed maculopathy or any other major eye disorder:
- Medical expenses incurred in the past and future to treat your injuries
- Both physical and mental pain and suffering from your injuries in the past and future
- Any loss of wages
- Other financial losses incurred
- Punitive damages, if applicable
Elmiron Lawsuit Settlement Amounts
It is still early in the development of the Elmiron lawsuit and there are no vision loss settlements yet. Our attorneys can’t forecast the Elmiron lawsuit settlement amounts with certainty. However, Elmiron settlement amounts can be estimated by comparing them to similar cases with similar injuries.
Vision impairment, macular degeneration, and vision loss are the main injuries suffered by Elmiron lawsuit plaintiffs. The settlement value of Elmiron litigation is based on vision loss or vision impairment injuries in other cases. Based on previous vision loss cases, our Elmiron attorneys predict that cases with total visual loss will have a high settlement value.
Elmiron lawsuit cases involving solely visual impairment will likely be grouped into levels based on the plaintiff’s amount of vision impairment. Permanent visual loss is the most extreme injury.
Plaintiffs with the most severe vision damage go in tier 1. Those with less impairment go in tier 2. There will probably be at least another two lower tiers of Elmiron lawsuit settlement amounts.
Bayer and Johnson & Johnson are comparable examples. Xarelto is a medication that has a lot of negative side effects. The most severely impacted people are estimated to have received between $75,000 and $300,000 as part of the settlement.
Contact an Elmiron Lawyer Today!
Contact your doctor and Houston Elmiron attorneys at Reich & Binstock if you’ve noticed any impaired vision after taking Elmiron. We can assist you in filing a claim and give you information on your right to compensation for pain and suffering. For a free consultation, please call us at 713-622-7271 or fill out the form below.